Clinical Study
Are Branded and Generic Extended-Release Ropinirole Formulations Equally Efficacious? A Rater-Blinded, Switch-Over, Multicenter Study
Table 3
Results of the poststudy patient questionnaire.
| Question | Responses (Requip/Ralnea/Similar) | Chi-square test |
| Overall which formulation had better efficacy? | 9/4/8 | 0.368 | Which formulation had better control on motor symptoms? | 10/3/8 | 0.156 | Which formulation had better control on nighttime symptoms? | 5/6/10 | 0.368 | Which formulation had better control on nonmotor symptoms? | 8/0/13 | 0.275 | Which formulation would you like to receive after the completion of the study? | 12/9 | 0.513 |
|
|